SUMOylation regulates the transcriptional activity of JunB in T lymphocytes

Journal of Immunology

Volumn 180, Issue 9, 2008, Pages 5983-5990

  Garaude, Johan ^a,b,c   Farrás, Rosa ^a,d   Bossis, Guillaume ^a   Charni, Seyma ^a   Piechaczyk, Marc ^a   Hipskind, Robert A ^a   Villalba, Martin ^a,b  

^a CNRS   (France)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4; LYSINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN UBC9; SUMO 2 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB; UBIQUITIN CONJUGATING ENZYME E2; CYTOKINE; PROTEIN C JUN; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR NFAT; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME UBC9; UBIQUITIN-CONJUGATING ENZYME UBC9;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL FRACTIONATION; CHROMATIN; CONJUGATION; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPORTER GENE; SUMOYLATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; DNA RESPONSIVE ELEMENT; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; PROTEIN PROCESSING; TRANSACTIVATION;

CD4-POSITIVE T-LYMPHOCYTES; CHROMATIN; CYTOKINES; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; NFATC TRANSCRIPTION FACTORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-JUN; RESPONSE ELEMENTS; SUMO-1 PROTEIN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; UBIQUITIN-CONJUGATING ENZYMES;

EID: 44449090072     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.9.5983     Document Type: Article

References (57)

1. Wagner, E. F. 2001. AP-1: introductory remarks. Oncogene. 20: 2334-2335. (Pubitemid 32531292)
2. Karamouzis, M. V., P. A. Konstantinopoulos, and A. G. Papavassiliou. 2007. The activator protein-1 transcription factor in respiratory epithelium carcinogenesis. Mol. Cancer Res. 5: 109-120. (Pubitemid 46423992)
3. Shaulian, E., and M. Karin. 2001. AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400. (Pubitemid 32531297)
4. Passegue, E., and E. F. Wagner. 2000. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J. 19: 2969-2979. (Pubitemid 30386768)
5. Li, B., C. Tournier, R. J. Davis, and R. A. Flavell. 1999. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J. 18: 420-432.
6. Bakiri, L., D. Lallemand, E. Bossy-Wetzel, and M. Yaniv. 2000. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J. 19: 2056-2068. (Pubitemid 30237581)
7. Schorpp-Kistner, M., Z. Q. Wang, P. Angel, and E. F. Wagner. 1999. JunB is essential for mammalian placentation. EMBO J. 18: 934-948. (Pubitemid 29082273)
8. Passegue, E., W. Jochum, M. Schorpp-Kistner, U. Mohle-Steinlein, and E. F. Wagner. 2001. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell 104: 21-32. (Pubitemid 32144969)
9. Passegue, E., E. F. Wagner, and I. L. Weissman. 2004. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 119: 431-443. (Pubitemid 39423844)
10. Yang, M. Y., T. C. Liu, J. G. Chang, P. M. Lin, and S. F. Lin. 2003. JunB gene expression is inactivated by methylation in chronic myeloid leukemia. Blood 101: 3205-3211. (Pubitemid 36858016)
11. Szremska, A. P., L. Kenner, E. Weisz, R. G. Ott, E. Passegue, M. Artwohl, M. Freissmuth, R. Stoxreiter, H. C. Theussl, S. B. Parzer, et al. 2003. JunB inhibits proliferation and transformation in B-lymphoid cells. Blood 102: 4159-4165. (Pubitemid 37487003)
12. Ott, R. G., O. Simma, K. Kollmann, E. Weisz, E. M. Zebedin, M. Schorpp-Kistner, G. Heller, S. Zochbauer, E. F. Wagner, M. Freissmuth, and V. Sexl. 2007. JunB is a gatekeeper for B-lymphoid leukemia. Oncogene 26: 4863-4871. (Pubitemid 47093176)
13. Steidl, U., F. Rosenbauer, R. G. Verhaak, X. Gu, A. Ebralidze, H. H. Otu, S. Klippel, C. Steidl, I. Bruns, D. B. Costa, et al. 2006. Essential role of Jun family transcription factors in PU. 1 knockdown-induced leukemic stem cells. Nat. Genet. 38: 1269-1277. (Pubitemid 44646289)
14. Hsu, F. Y., P. B. Johnston, K. A. Burke, and Y. Zhao. 2006. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner. Cancer Res. 66: 9002-9008. (Pubitemid 44521118)
15. Mao, X., G. Orchard, D. M. Lillington, F. J. Child, E. C. Vonderheid, P. C. Nowell, M. Bagot, A. Bensussan, R. Russell-Jones, B. D. Young, and S. J. Whittaker. 2004. BCL2 and JUNB abnormalities in primary cutaneous lymphomas. Br. J. Dermatol. 151: 546-556. (Pubitemid 39330877)
16. Mao, X., G. Orchard, D. M. Lillington, R. Russell-Jones, B. D. Young, and S. J. Whittaker. 2003. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood 101: 1513-1519. (Pubitemid 36182528)
17. + lymphomas and lymphomatoid papulosis. Mod. Pathol. 18: 1365-1370.
18. Al-Shamkhani, A. 2004. The role of CD30 in the pathogenesis of haematopoietic malignancies. Curr. Opin. Pharmacol. 4: 355-359. (Pubitemid 38987061)
19. Hartenstein, B., S. Teurich, J. Hess, J. Schenkel, M. Schorpp-Kistner, and P. Angel. 2002. Th2 cell-specific cytokine expression and allergen-induced airway inflammation depend on JunB. EMBO J. 21: 6321-6329. (Pubitemid 35448410)
20. Flavell, R. A., M. Rincon, W. P. Zheng, B. Li, H. Enslen, J. Raingeaud, and R. J. Davis. 1998. The regulation of CD4 T cell differentiation. Eur. Cytokine Network 9: 26-32. (Pubitemid 28508759)
21. Jain, J., V. E. Valge-Archer, and A. Rao. 1992. Analysis of the AP-1 sites in the IL-2 promoter. J. Immunol. 148: 1240-1250.
22. Jain, J., C. Loh, and A. Rao. 1995. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7: 333-342.
23. Bunting, K., J. Wang, and M. F. Shannon. 2006. Control of interleukin-2 gene transcription: a paradigm for inducible, tissue-specific gene expression. Vitam. Horm. 74: 105-145.
24. Schwartz, R. H. 1997. T cell clonal anergy. Curr. Opin. Immunol. 9: 351-357. (Pubitemid 27303504)
25. Mondino, A., C. D. Whaley, D. R. DeSilva, W. Li, M. K. Jenkins, and D. L. Mueller. 1996. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells. J. Immunol. 157: 2048-2057. (Pubitemid 126449680)
26. + T lymphocytes. Transplantation 72: 1416-1422.
27. + T cells have defective expression and function of the activating protein-1 transcription factor. J. Immunol. 161: 5930-5936.
28. Kallunki, T., T. Deng, M. Hibi, and M. Karin. 1996. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87: 929-939. (Pubitemid 26404291)
29. Gupta, S., T. Barrett, A. J. Whitmarsh, J. Cavanagh, H. K. Sluss, B. Derijard, and R. J. Davis. 1996. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15: 2760-2770. (Pubitemid 26176253)
30. Gao, M., T. Labuda, Y. Xia, E. Gallagher, D. Fang, Y. C. Liu, and M. Karin. 2004. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 306: 271-275. (Pubitemid 39336871)
31. Fang, D., C. Elly, B. Gao, N. Fang, Y. Altman, C. Joazeiro, T. Hunter, N. Copeland, N. Jenkins, and Y. C. Liu. 2002. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nat. Immunol. 3: 281-287. (Pubitemid 34213430)
32. Hay, R. T. 2005. SUMO: a history of modification. Mol. Cell. 18: 1-12. (Pubitemid 40444643)
33. Seeler, J. S., and A. Dejean. 2003. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4: 690-699. (Pubitemid 37082184)
34. Bossis, G., and F. Melchior. 2006. SUMO: regulating the regulator. Cell Div. 1: 13. (Pubitemid 46731041)
35. Gill, G. 2005. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15: 536-541. (Pubitemid 41262410)
36. Bossis, G., C. E. Malnou, R. Farras, E. Andermarcher, R. Hipskind, M. Rodriguez, D. Schmidt, S. Muller, I. Jariel-Encontre, and M. Piechaczyk. 2005. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol. Cell. Biol. 25: 6964-6979. (Pubitemid 41105897)
37. Wei, F., H. R. Scholer, and M. L. Atchison. 2007. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J. Biol. Chem. 282: 21551-21560. (Pubitemid 47099909)
38. Terui, Y., N. Saad, S. Jia, F. McKeon, and J. Yuan. 2004. Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. J. Biol. Chem. 279: 28257-28265. (Pubitemid 38900103)
39. Bossis, G., and F. Melchior. 2006. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol. Cell. 21: 349-357. (Pubitemid 43163530)
40. Garaude, J., S. Cherni, S. Kaminski, E. Delepine, C. Chable-Bessia, M. Benkirane, J. Borges, A. Pandiella, M. A. Iniguez, M. Fresno, et al. 2006. ERK5 activates NF-κB in leukemic T cells and is essential for their growth in vivo. J. Immunol. 177: 7607-7617.
41. Villalba, M., N. Coudronniere, M. Deckert, E. Teixeiro, P. Mas, and A. Altman. 2000. A novel functional interaction between Vav and PKCθ is required for TCR-induced T cell activation. Immunity 12: 151-160. (Pubitemid 30398629)
42. Ho, I. C., M. R. Hodge, J. W. Rooney, and L. H. Glimcher. 1996. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85: 973-983. (Pubitemid 26231165)
43. Villalba, M., S. Kasibhatla, L. Genestier, A. Mahboubi, D. R. Green, and A. Altman. 1999. Protein kinase cθ cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death. J. Immunol. 163: 5813-5819.
44. Villalba, M., K. Bi, J. Hu, Y. Altman, P. Bushway, E. Reits, J. Neefjes, G. Baier, R. T. Abraham, and A. Altman. 2002. Translocation of PKCθ in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J. Cell Biol. 157: 253-263.
45. Swainson, L., S. Kinet, C. Mongellaz, M. Sourisseau, T. Henriques, and N. Taylor. 2007. IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway. Blood 109: 1034-1042. (Pubitemid 46220649)
46. Wysocka, J., P. T. Reilly, and W. Herr. 2001. Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells. Mol. Cell. Biol. 21: 3820-3829. (Pubitemid 32466993)
47. Foletta, V. C., D. H. Segal, and D. R. Cohen. 1998. Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukocyte Biol. 63: 139-152. (Pubitemid 28116496)
48. Isakov, N., and A. Altman. 2002. Protein kinase Cθ in T cell activation. Annu. Rev. Immunol. 20: 761-794.
49. Muller, S., M. Berger, F. Lehembre, J. S. Seeler, Y. Haupt, and A. Dejean. 2000. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275: 13321-13329. (Pubitemid 30257389)
50. Wei, F., H. R. Scholer, and M. L. Atchison. 2007. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J. Biol. Chem. 282: 21551-21560. (Pubitemid 47099909)
51. Salinas, S., A. Briancon-Marjollet, G. Bossis, M. A. Lopez, M. Piechaczyk, I. Jariel-Encontre, A. Debant, and R. A. Hipskind. 2004. SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1. J. Cell Biol. 165: 767-773. (Pubitemid 38821967)
52. Boise, L. H., B. Petryniak, X. Mao, C. H. June, C. Y. Wang, T. Lindsten, R. Bravo, K. Kovary, J. M. Leiden, and C. B. Thompson. 1993. The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB. Mol. Cell. Biol. 13: 1911-1919. (Pubitemid 23068131)
53. Kagey, M. H., T. A. Melhuish, and D. Wotton. 2003. The polycomb protein Pc2 is a SUMO E3. Cell 113: 127-137. (Pubitemid 36411965)
54. Yang, S. H., E. Jaffray, R. T. Hay, and A. D. Sharrocks. 2003. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell. 12: 63-74. (Pubitemid 36945037)
55. Verger, A., J. Perdomo, and M. Crossley. 2003. Modification with SUMO. A role in transcriptional regulation. EMBO Rep. 4: 137-142. (Pubitemid 36322153)
56. Shyu, Y. C., T. L. Lee, C. Y. Ting, S. C. Wen, L. J. Hsieh, Y. C. Li, J. L. Hwang, C. C. Lin, and C. K. Shen. 2005. Sumoylation of p45/NF-E2: nuclear positioning and transcriptional activation of the mammalian β-like globin gene locus. Mol. Cell. Biol. 25: 10365-10378. (Pubitemid 41681961)
57. Osborne, C. S., L. Chakalova, K. E. Brown, D. Carter, A. Horton, E. Debrand, B. Goyenechea, J. A. Mitchell, S. Lopes, W. Reik, and P. Fraser. 2004. Active genes dynamically colocalize to shared sites of ongoing transcription. Nat. Genet. 36: 1065-1071. (Pubitemid 41184467)